Research library
Longevity/peptide

Epitalon

Canonical identity: Epitalon

Also indexed as: Epithalon

A synthetic tetrapeptide associated with limited and largely preclinical aging-related literature.

Evidence level

Preclinical evidence

Verified against the linked source set on 2026-08-20.

What it is

Epitalon, also spelled Epithalon, is a synthetic tetrapeptide studied in aging, telomere, and cellular biology research.

Mechanism and research questions

  • Proposed mechanisms include effects on cellular stress and telomere-related biology, but the evidence is not settled.
  • Marketing claims frequently exceed the quality of the available research.

Human evidence

No robust human clinical program supporting general longevity claims was identified in the initial audit.

Preclinical / mechanistic evidence

Animal and cell studies explore aging-related endpoints, with substantial uncertainty about translation.

Evidence summary

The literature includes experimental and review material, but robust modern human efficacy evidence is not established.

Limits and interpretation

  • Do not present longevity claims as established human outcomes.
  • Historical studies require careful review of design and replication.
  • No dosing or self-experimentation advice is provided.

Regulatory and identity note

Research-use peptide; not presented as approved anti-aging therapy.

Research summaries reflect primary literature, patent landscapes, and regulatory status reports at the time of review. They do not constitute therapeutic advice, endorsement, or claims regarding unauthorized preparations.